| Metric | შპს დენკ ფარმა კავკასია | შპს ივერმედი |
|---|---|---|
| Growth | ||
| Revenue | ₾22.1m₾20.5m | ₾45.9m₾47.1m |
| Revenue growth | 7.7% | -2.5% |
| Profitability | ||
| EBITDA | ₾2.4m₾833k | -₾1.1m₾3.1m |
| EBITDA margin | 10.7%4.1% | -2.4%6.6% |
| Net profit | ₾1.4m₾589k | -₾993k₾4.4m |
| Net margin | 6.4%2.9% | -2.2%9.3% |
| Balance sheet | ||
| Total assets | ₾13.2m₾11.6m | ₾38.9m₾42.4m |
| Total equity | ₾4.6m₾4.7m | ₾30.8m₾35.6m |
| ROE | 30.4%12.5% | -3.2%12.3% |